Obesity and Androgen Receptor Signaling: Associations and Potential Crosstalk in Breast Cancer Cells
Open Access
- 6 May 2021
- Vol. 13 (9), 2218
- https://doi.org/10.3390/cancers13092218
Abstract
Obesity is an increasing health challenge and is recognized as a breast cancer risk factor. Although obesity-related breast cancer mechanisms are not fully understood, this association has been linked to impaired hormone secretion by the dysfunctional obese adipose tissue (hyperplasic and hypertrophic adipocytes). Among these hormones, altered production of androgens and adipokines is observed, and both, are independently associated with breast cancer development. In this review, we describe and comment on the relationships reported between these factors and breast cancer, focusing on the biological associations that have helped to unveil the mechanisms by which signaling from androgens and adipokines modifies the behavior of mammary epithelial cells. Furthermore, we discuss the potential crosstalk between the two most abundant adipokines produced by the adipose tissue (adiponectin and leptin) and the androgen receptor, an emerging marker in breast cancer. The identification and understanding of interactions among adipokines and the androgen receptor in cancer cells are necessary to guide the development of new therapeutic approaches in order to prevent and cure obesity and breast cancer.This publication has 183 references indexed in Scilit:
- DAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferationCell Death & Disease, 2013
- Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15Breast Cancer Research, 2013
- Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1The EMBO Journal, 2011
- Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFκB/HIF-1α activationCellular Signalling, 2010
- Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response elementNucleic Acids Research, 2010
- The LKB1–AMPK pathway: metabolism and growth control in tumour suppressionNature Reviews Cancer, 2009
- Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cellsBreast Cancer Research and Treatment, 2009
- Effects of adiponectin on breast cancer cell growth and signalingBritish Journal of Cancer, 2008
- Leptin-induced Growth Stimulation of Breast Cancer Cells Involves Recruitment of Histone Acetyltransferases and Mediator Complex to CYCLIN D1 Promoter via Activation of Stat3Online Journal of Public Health Informatics, 2007
- Cloning of adiponectin receptors that mediate antidiabetic metabolic effectsNature, 2003